These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20643924)

  • 1. Defining the determinants of nicotine selectivity.
    Taylor P
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13195-6. PubMed ID: 20643924
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic pharmacophore: the pyridine N of nicotine and carbonyl of acetylcholine hydrogen bond across a subunit interface to a backbone NH.
    Blum AP; Lester HA; Dougherty DA
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13206-11. PubMed ID: 20616056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor.
    Cashin AL; Petersson EJ; Lester HA; Dougherty DA
    J Am Chem Soc; 2005 Jan; 127(1):350-6. PubMed ID: 15631485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2. Medicinal chemistry of alpha4beta2 nicotinic cholinergic receptor ligands.
    Glennon RA
    Prog Med Chem; 2004; 42():55-123. PubMed ID: 15003719
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
    Rucktooa P; Haseler CA; van Elk R; Smit AB; Gallagher T; Sixma TK
    J Biol Chem; 2012 Jul; 287(28):23283-93. PubMed ID: 22553201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-receptor interaction at the neural nicotinic acetylcholine binding site: a theoretical model.
    Morreale A; Maseras F; Iriepa I; Gálvez E
    J Mol Graph Model; 2002 Oct; 21(2):111-8. PubMed ID: 12398342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding interactions with the complementary subunit of nicotinic receptors.
    Blum AP; Van Arnam EB; German LA; Lester HA; Dougherty DA
    J Biol Chem; 2013 Mar; 288(10):6991-7. PubMed ID: 23349463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing for and Quantifying Agonist Hydrogen Bonds in α6β2 Nicotinic Acetylcholine Receptors.
    Post MR; Lester HA; Dougherty DA
    Biochemistry; 2017 Apr; 56(13):1836-1840. PubMed ID: 28287260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the nature of molecular recognition in nicotinic acetylcholine receptors.
    Schmitt JD
    Curr Med Chem; 2000 Aug; 7(8):749-800. PubMed ID: 10828287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A perturbed pK(a) at the binding site of the nicotinic acetylcholine receptor: implications for nicotine binding.
    Petersson EJ; Choi A; Dahan DS; Lester HA; Dougherty DA
    J Am Chem Soc; 2002 Oct; 124(43):12662-3. PubMed ID: 12392404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationship of novel pyridyl ethers for the nicotinic acetylcholine receptor.
    Lee J; Davis CB; Rivero RA; Reitz AB; Shank RP
    Bioorg Med Chem Lett; 2000 May; 10(10):1063-6. PubMed ID: 10843217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine binding to brain receptors requires a strong cation-pi interaction.
    Xiu X; Puskar NL; Shanata JA; Lester HA; Dougherty DA
    Nature; 2009 Mar; 458(7237):534-7. PubMed ID: 19252481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A touching picture of nicotinic binding.
    Karlin A
    Neuron; 2004 Mar; 41(6):841-2. PubMed ID: 15046715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural model of nicotinic acetylcholine receptor isotypes bound to acetylcholine and nicotine.
    Schapira M; Abagyan R; Totrov M
    BMC Struct Biol; 2002; 2():1. PubMed ID: 11860617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal nicotinic acetylcholine receptors as targets for drug discovery.
    Holladay MW; Dart MJ; Lynch JK
    J Med Chem; 1997 Dec; 40(26):4169-94. PubMed ID: 9435889
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of 5-substituted pyridine analogues of 3.
    Lin NH; Li Y; He Y; Holladay MW; Kuntzweiler T; Anderson DJ; Campbell JE; Arneric SP
    Bioorg Med Chem Lett; 2001 Mar; 11(5):631-3. PubMed ID: 11266158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-acetylcholine displaceable 3[H]epibatidine binding in the rat brain.
    Plenge P; Mellerup E
    Neurosci Lett; 1998 May; 248(1):65-7. PubMed ID: 9665665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining nicotinic agonist binding surfaces through photoaffinity labeling.
    Tomizawa M; Maltby D; Medzihradszky KF; Zhang N; Durkin KA; Presley J; Talley TT; Taylor P; Burlingame AL; Casida JE
    Biochemistry; 2007 Jul; 46(30):8798-806. PubMed ID: 17614369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A triad of residues is functionally transferrable between 5-HT
    Mosesso R; Dougherty DA
    J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative structure-activity relationships of nicotine analogues as neuronal nicotinic acetylcholine receptor ligands.
    Kim KH; Lin NH; Anderson DJ
    Bioorg Med Chem; 1996 Dec; 4(12):2211-7. PubMed ID: 9022984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.